Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
192 participants
INTERVENTIONAL
2001-07-31
2006-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Clinic-based, Multi- Disciplinary, Pediatric Weight Management Program
NCT01857791
Wellness and Weight Family Group Project
NCT02677792
Guided Self-help for Families With an Overweight Child
NCT01145833
Reducing Obesity Through Play Among Toddlers: Tiny Steps to Health (TSHS) Study
NCT06918821
Examination of a Treatment Program for Overweight Children, Adolescents, and Their Families
NCT00365807
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Two hundred children aged 8-12 will be randomized to a six-month family-based program or usual care, and will complete assessments at pre- and post- treatment and 6-month and 12-month follow-ups. We hypothesized that: 1) Children who participate in the family-based program, when compared to children who receive usual care, will show favorable changes in body mass index, body composition, food intake, activity level, and cardiovascular risk factors. 2) Children who participate in the family-based program, when compared to children who receive usual care, will report higher levels of self-esteem, social competence and health-related quality of life, and report fewer psychiatric symptoms. A secondary aim of the the proposed investigation is to examine the relationships among gender, race, compliance to diet and exercise. level of parent adherence and treatment outcome. The proposed investigation is significant as the first effort to systematically evaluate a treatment program for severely obese children. It will provide data about a serious public health problem and establish a foundation for programmatic research to develop effective treatments for an underserved population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Enhanced usual care: 2 free, individual consultations with a nutritionist over first 6 months. Medical monitoring throughout study period.
No interventions assigned to this group
B
Family-based treatment
20 weekly group contacts with individual coaching over first 6 months, brief monthly contacts over next 6 months, no contacts over last 6 months. Medical monitoring throughout study period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Family-based treatment
20 weekly group contacts with individual coaching over first 6 months, brief monthly contacts over next 6 months, no contacts over last 6 months. Medical monitoring throughout study period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have at least one parent or guardian who will participate in the treatment program with child.
Exclusion Criteria
* Genetic obesity syndrome as determined by the study physician.
* Currently receiving obesity treatment and/or participating in a weight management program.
* Inability to engage in moderate exercise defined as 30 minutes of vigorous activity on most days of the week.
* Acute or severe medical conditions that require aggressive weight management intervention (e.g., diabetes pseudotumor cerebri, or hypoventilation).
* Regular use of a medication that affects body weight such as oral steroids or antipsychotic medications.
* Taking stimulant or antidepressant medication for a period \< four months.
8 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Pittsburgh School of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marsha D. Marcus, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Western Psychiatric Insitute & Clinic
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0405048
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.